Skip to content
10-Q

Quarterly Report

REVELATION BIOSCIENCES, INC. REVB REVBW

0000950170-25-105284

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 1.7M sh
Shares Diluted Q2 2025 · Jun 30, 2025 802.67K sh
Shares Diluted Q2 2025 · Jun 30, 2025 564.56K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.71M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $5.17M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $6.5M
Stockholders Equity Q2 2025 · Jun 30, 2025 $3.83M
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.88M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.71M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.57M
Current Liabilities Q2 2025 · Dec 31, 2024 $1.91M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.57M
Total Liabilities Q2 2025 · Dec 31, 2024 $1.91M
Current Assets Q2 2025 · Jun 30, 2025 $5.36M
Current Assets Q2 2025 · Dec 31, 2024 $6.57M
Total Assets Q2 2025 · Jun 30, 2025 $5.4M
Total Assets Q2 2025 · Dec 31, 2024 $6.62M
Eps Diluted Q2 2025 · Jun 30, 2025 −$7.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$13.60
Eps Basic Q2 2025 · Jun 30, 2025 −$7.01
Eps Basic Q2 2025 · Jun 30, 2025 −$13.60
Sga Expense Q2 2025 · Jun 30, 2025 $1.14M
Sga Expense Q2 2025 · Jun 30, 2025 $2.38M
Rd Expense Q2 2025 · Jun 30, 2025 $1.32M
Rd Expense Q2 2025 · Jun 30, 2025 $2.18M
Net Income Q2 2025 · Jun 30, 2025 −$2.44M
Net Income Q2 2025 · Jun 30, 2025 −$4.5M
Net Income Q2 2025 · Mar 31, 2025 −$2.05M
Operating Income Q2 2025 · Jun 30, 2025 −$2.46M
Operating Income Q2 2025 · Jun 30, 2025 −$4.56M